Second Trump Administration Impact on 340B Program to Be Determined

Originally published by our sister publication Specialty Pharmacy Continuum

By Karen Blum
How could the second Trump administration affect the federal 340B Drug Pricing Program? It’s yet to be determined, according to a policy expert.